A study by Schnorfeil et al. demonstrated that cytokine production and proliferation of T-cells from AML patients with different diseases are unimpaired (in addition to reduced CD4+ IFN-γ production), with PD-1 overexpression representing differentiated effector T-cells, not exhaustion [168]. The gene discussed is CD4; the disease is acute myeloid leukemia.